Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Maya Lathi"'
Autor:
Frank C. Stomski, Winnie L. Kan, Mara Dottore, Ravindra Majeti, Vinay Tergaonkar, Timothy P. Hughes, Jeffrey J. Babon, Denis Tvorogov, Daniel Thomas, Nicholas P. D. Liau, Angel F. Lopez, Maya Lathi, Timothy R. Hercus, Michael W. Parker, David M. Ross, Emma F Barry
Publikováno v:
Science Advances
Pathological drug withdrawal syndrome is linked to accumulation of JAK2 phosphorylation in V617F myelofibrosis.
Treatment of patients with myelofibrosis with the type I JAK (Janus kinase) inhibitor ruxolitinib paradoxically induces JAK2 activati
Treatment of patients with myelofibrosis with the type I JAK (Janus kinase) inhibitor ruxolitinib paradoxically induces JAK2 activati
Autor:
Ravindra Majeti, Timothy P. Hughes, Nicholas P. D. Liau, Frank C. Stomski, David M. Ross, Winnie L. Kan, T.R. Hercus, Denis Tvorogov, Michael W. Parker, Vinay Tergaonkar, Jeffrey J. Babon, Angel F. Lopez, Daniel Thomas, Emma F Barry, Maya Lathi, Mara Dottore
Publikováno v:
Blood. 132:1787-1787
Patients with myelofibrosis who are treated with the Type I ATP competitive JAK inhibitor ruxolitinib derive symptomatic benefit from improvement in cytokine-mediated symptoms, and show cytoreductive responses in disease manifestations, such as splen